Lombaard J, Ssali F, Moolasart V, Guarino A, et al. Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2 Pediatr Infect Dis J 2025 Aug 13. doi: 10.1097/INF.0000000000004943.
PMID: 40829134